Virax Biolabs Group Ltd. Class A Stock (VRAX)

Track Virax Biolabs Group Ltd. Class A stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.

$2.80
▼ -16.52 (-85.02%) past year
$5.00$10$15$20Aug '25Oct '25Dec '25Mar '26May '26Aug '26
Market Cap
$2.09M
P/E Ratio
—
1Y Return
-85.02%
EPS (TTM)
-$16.91

Read the latest TheStreet Pro articles mentioning Virax Biolabs Group Ltd. Class A, including market roundups, portfolio updates, trade ideas, and investing analysis.

Articles

0 articles

No articles mentioning VRAX yet.

Daily Diary Mentions

0 mentions

No diary mentions for VRAX yet.